Company profile

Genemark company profile

GENEMARK processes generic drugs (anti-infectious, anti-parasitic, anti-inflammatory …) and aims at the largest distribution scale thanks to an offer 30% to 50% cheaper than classical drugs. Genemark developers favor the production of liquid drugs (15 references over 27) in order to reduce overdose risks, particularly high in paludism treatments for children.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$0+

Headquarters

Headquarters
Douala, Littoral, Cameroon
Postal code
15515
Country code
CM
Continent
Africa

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Series Unknown / 2008-01-01
Last equity funding
Series Unknown
Investors
1
Lead investors
1

Founders and investors

Lead investors

Investisseurs & Partenaires

Investors

Investisseurs & Partenaires

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.